Upstate Active Clinical Trials
Study Title:
Phase One, Open Label, Homologous Reinfection with Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) or Dengue-3-Virus-Live Virus Human Challenge (DENV-3-LVHC) Virus StrainsWhat is the purpose of the study? (in Layman's terms, please describe the study)
To investigate the response of subjects to a re-inoculation with the same strain of dengue virus, or to investigate the response of subjects who have never been inoculated with or had dengue virusUpstate Institutional Review Board (IRB) Number:
2079925Study/Protocol ID:
2023-01-UMUStudy Phase:
1Patient Age Group:
AdultsPrincipal Investigator:
Stephen J ThomasWho is eligible?
Adults age 18-55What is involved if I participate?
- How long is the study?
6-9 monts - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
Blood draws, inoculation with dengue virus, maintaining an e-diary
Where will the study take place?
Global Health Research Unit4900 Broad Rd, POB-North Suite 4U
Syracuse NY 13215
Other Information:
May not be immunosuppressed, must be able to commit to frequent in-person and phone visits.Who can I contact for more information?
Name: Carrington A Baker, BS
Phone: 315-464-5729
Email: [email protected]